AMA Internal Medicine commentary highlights opportunity to discover modifiable risk factor for dementia
In a commentary published in JAMA Internal Medicine, three Regenstrief Institute research scientists write that while they and other researchers have identified a strong and consistent link between anticholinergic drugs and ...
Jun 24, 2019
0
1